Society News

MASCC Society News - August Issue

August 2019

Any news items to share? Send them to [email protected]

From the Editor

This month, we introduce MASCC's newest affiliate, the Russian Society of Supportive Care in Oncology. MASCC President Dr. Rajesh Lalla discusses efforts to grow MASCC membership. We also focus on neurological complications of cancer and its treatment with a profile of the Neurological Complications Study Group, led by Drs. Maryam Lustberg and Alex Chan, as well as a research highlight on risk factors for chemotherapy-induced peripheral neuropathy. A second research highlight summarizes the work of Dr. Maryam Lustberg and her colleagues on early detection of anthracycline-induced cardiotoxicity in breast cancer survivors. As usual, we include several conference reminders and deadlines. We extend a warm welcome to new members who joined us in June. And we encourage every member to be a voice for MASCC!  

All issues of the MASCC Society News are available online at Older issues (through August, 2016) can be found in the back pages of our journal, Supportive Care in Cancer.

~ Toni Clark, Editor

Message from the President,
Rajesh Lalla, DDS, PhD

Dear Colleagues,

A major focus of my second year as MASCC President will be on growing our membership. This is crucial to achieving our mission of advancing supportive care in cancer worldwide. We will be working on a couple of different initiatives towards this goal. First, we will continue to actively expand the number of MASCC affiliates. As you know, over the last several months, we have signed affiliate agreements with national-level supportive care organizations in France, India, Italy, and Russia. All members of these affiliate organizations will also be MASCC members. The list of new members in this issue shows a number of new members from France and Italy. We will soon be adding the 340 members of our newest affiliate, the Russian Society of Supportive Care in Oncology (RASSC). These partnerships strengthen both MASCC and our national-level affiliates. Together, we are building a united global network of organizations dedicated to supportive care in cancer that will benefit our patients.

A second initiative, led by the MASCC Membership Committee, will be to increase the number of new and renewing individual members. Over the last several months, members of this committee have been actively reaching out to colleagues whose memberships have lapsed to encourage them to renew. I would like to thank and recognize them for their efforts: Chair Dr. Annie Young and Members Drs. Thomas Butler, Alexandre Chan, Corina van den Hurk, Micah Peters, and MASCC Executive Director Ms. Melissa Chin. The Membership Committee has already had some discussions on ideas to incentivize new and renewing individual members. They will have my full support and engagement to develop and roll out this program.

Best Wishes,

Meeting Sessions Now Online MASCC/ISOO 2019
San Francisco, CA
June 21-23

Slides are now available on the MASCC website from the 2019 Workshops, Meet-the-Expert, Plenary, Parallel and Joint Sessions.

A few sessions are missing. The availability of slides is at the discretion of each presenter. All slide presentations are converted to PDF to optimize file size. 

Go to meeting session slides - (MASCC member login required)
Go to E-posters
Stay tuned for photos to be posted in late August.


Russian Society of Supportive Care in Oncology (RASSC)

As Dr. Rajesh Lalla noted in his President's Message in our July issue, MASCC has recently signed an affiliation agreement with the Russian Society of Supportive Care in Oncology (RASSC). RASSC is led by Dr. Anton Snegovoy, Chairman of RASSC, and Dr. Inessa Kononenko, Executive Director. The affiliation includes the reciprocal agreement that all members of RASSC automatically become MASCC members and all current MASCC members residing in the Russian Federation become members of RASSC. The mission and goals of RASSC include promoting an alliance of diverse specialists concerned with supportive care of cancer patients in Russia and improving professional knowledge, skills, and practice in supportive cancer care. In addition, the RASSC works to attract public interest in supportive care issues. The Society will hold its third International Symposium on Supportive Therapy in Oncology: From Theory to Practice in Chelyabinsk, Russia on October 4, 2019. Read more

PROFILE: MASCC's Neurological Complications Study Group

MASCC's Neurological Complications Study Group was formed to raise awareness among healthcare providers, patients, and advocacy groups about the frequency, importance, and complexity of neurological complications secondary to radiation and chemotherapy. These problems are important to all patients with cancer. Hence a multidisciplinary approach is essential in addressing the Study Group's primary objectives which, among others, include developing reliable assessment tools, assessing the significance of neurological complications internationally, and forming international multidisciplinary collaborations on emerging modalities.

Currently led by Dr. Maryam Lustberg, Chair and Dr. Alex Chan, Vice-Chair, the Study Group conducts research on both chemotherapy-induced peripheral neuropathy (CIPN) and cancer-related cognitive impairment (CRCI). Recent research by Study Group members includes numerous studies exploring the risk factors, incidence, assessment, and disease burden of cognitive and peripheral neuropathy, as well as their prevention and treatments. Many studies explore the symptom burden and quality of life of cancer patients and survivors who have been treated with neurotoxic chemotherapies. This year, the Study Group recognized outstanding work by its members with two awards for outstanding abstracts submitted to the MASCC/ISOO Annual Meeting. The recipients were Alex Molassiotis, RN, PhD, and Yi Long Toh, BSc Pharm.

Future work will include small research working groups on financial toxicity of neurological complications, special issues faced by young and older cancer survivors, integrative medicine approaches, and emerging technologies for neurological symptom management. The Study Group Leaders are happy to accept new members and invite them to engage in ongoing or new projects. Read more and get involved!

Risk Factors for Chemotherapy-Induced Peripheral Neuropathy

Dr. Alex Molassiotis and Dr. Alex Chan are among the co-authors of a recent study of risk factors for chemotherapy-induced peripheral neuropathy (CIPN) among patients receiving taxane-based and platinum-based chemotherapy. CIPN is a significant side effect of neurotoxic chemotherapies and one that is difficult to manage. Although several risk factors for CIPN have been identified, methodological limitations in much past research limit knowledge about such risks. Molassiotis and his colleagues undertook this study to assess the relative contributions of a wider range of potential risk factors than previously studied. The authors analyzed data from a larger prospective observational study on CIPN risk, prevalence, and quality of life among cancer patients in Hong Kong, Singapore, and the UK. Their findings confirmed the CIPN risk of some previously identified variables and suggested others. Key risk factors included older age, type of chemotherapy, history of neuropathy, symptom burden, number of chemotherapy cycles received, and alcohol intake. Patients receiving platinum¿based chemotherapy had a lower risk of CIPN than those receiving taxane¿based chemotherapy across all CIPN scales used. Also, a particularly high incidence of CIPN was observed in patients who received paclitaxel. Greater knowledge about these risk factors can help in educating patients about treatment side effects and could lead to more regular assessment of CIPN, particularly in patients at higher risk. Read more.

Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors

Anthracycline therapy is a mainstay for breast cancer and many other cancers, but it is associated with a rate of incident heart failure more than five times the average. Preclinical studies of anthracycline-induced myocardial damage show that the substrate for heart failure is myocardial fibrosis preceded by myocardial edema or inflammation. Loss of endothelial progenitor cells (EPCs) may also contribute to myocardial damage. The detection of early changes via blood biomarkers is challenging, but recently, cardiac magnetic resonance (CMR) has been successfully used to detect post-treatment anthracycline-induced fibrosis through T1 mapping, paralleling a decline in left ventricular ejection fraction (LVEF).

Dr. Maryam Lustberg and her colleagues at The Ohio State University's James Comprehensive Cancer Center conducted a prospective study to test the hypothesis that myocardial edema could be detected by the CMR relaxation parameter T2, comparing its value to EPC assay in women receiving anthracyline therapy for breast cancer. They studied 29 women, aged 54±10 years, with nonmetastatic breast cancer who were receiving neoadjuvant or adjuvant therapy with the anthracycline doxorubicin. The primary outcome was a change in myocardial T2 following anthracycline initiation. They found significant increases in T2 after the first anthracycline treatment, but no significant change in LVEF or circumferential strain. A similar pattern was observed after completion of treatment, with an even greater increase in T2. Early myocardial inflammation, as indicated by T2 increase, appeared to be associated with anthracycline administration even before fibrosis, abnormal strain, or decline in LVEF. This work provides a basis for further research to evaluate early myocardial T2 change as a potential biomarker - as a basis for risk stratification and a target for cardioprotective strategies. Read more.

Upcoming Conferences

September 6-7, 2019
The 4th Annual Meeting of the Japanese Association of Supportive Care in Cancer
Aomori, Japan

September 14-15, 2019
2019 Best of MASCC, India
Mumbai, India

Sept. 27-Oct. 1, 2019
EONS12 - European Oncology Nursing Society
At ESMO2019
Barcelona, Spain

Sept. 27-Oct. 1, 2019
ESMO 2019 Congress
Translating Science into Better Cancer Patient Care
Barcelona, Spain

October 4, 2019
III International Symposium - Supportive Therapy in Oncology: From Theory to Practice
Chelyabinsk, Russia

October 19-21, 2019
16th International Conference on Integrative Oncology
Advancing the Science & Art of Integrative Oncology
New York City, New York

October 25-26, 2019
Annual Cancer Treatment-Related Adverse Events Symposium
Memorial Sloan Kettering Cancer Center, New York, NY

November 14-15, 2019
7th Conference of the Scientific Network on Female Sexual Health and Cancer
"Improving Sexual Health for Adolescent and Young Adult Survivors"
Columbus, Ohio, USA

November 14-16, 2019
19th Conference of the International Society of Geriatric Oncology
'Integrative Oncology - Leaving No One Behind"
Geneva, Switzerland

November 29-30, 2019
The Third Regional Education Meeting on Supportive Care in Cancer Patients for Eastern Europe and Balkan Region
Belgrade, Serbia

Connect With Us!


Twitter Quick Guide

Plan Ahead for 2020!

Seville, Spain
June 25-27, 2020

Did you forget your Photo Booth Photo from California Dreaming Dinner? Get it now!

New MASCC Members

A warm welcome to the new members who joined us in June!

Hanlie Engelbrecht
Herman Lau
Rhiannon Mellor
Janette Perz
Jane Ussher

Christine Brunner

Graziella Jaguar

Marie Francoise Scharll

Naser Alqurini
Patricia Campbell
Colleen Cuthbert
Marc Gaudet
Amanda Gruza
Aaron Johnson

Ignacio Retamal

Erick Andres Cantor Rizo

Philippe Atlan
Karine Beerblock
Frantz Berkelmans
Carole Bouleuc
Catherine Bourrieres
Guillaume Buiret
Nathalie Caunes-Hilary
Stephane Cheze
Arnaud Desplechin
Mario Di Palma
Didier Kamioner
Christine Préaubert-Sicaud
Audrey Rambeau
Evelyne Strechinsky
Veronique Verspyck

Irene Alabisco
Marco Ali
Fabio Calabro
Verena De Angelis
Guglielmo Fumi
Vittorio Fusco
Mara Murru

Dalia Skorupskiene

Antje Roeniger Desatnik
Enrique Soto Perez de Celis

Miro Rodriguez Inocente

Filipa Macedo

Nilay Aksoy

United Kingdom
Richard Berman

United States
Elena Alcedo
Colette Allen
Christina Baggott
Catherine Benedict
Donna Berry
Deborah Bolton
Lauren Bruckner
Lisa Conte
Anna Dowling
Susan Gilchrist
Yuko Hamajima
Josef Hannah
Maureen Huhmann
Jennifer Kelley
Dori Klemanski
Tiffany Kneuss
Claire Larible-Lefort
Ricky McCullough
Jill Mosby
Timiya Nolan
Armida Parala-Metz
Carolyn Patrick
Sandra Reese
Paul Sloan
Kelay Trentham

Help Spread the Word!

Our 2020 Annual Meeting will take place on June 25-27 in Seville, Spain.
2020 Promotional Toolkit -  Here you can find PowerPoint slide sets, banners, adverts, and signature banners to use in your email signature files. We encourage all members to take advantage of these resources and let your colleagues know about MASCC and our next meeting.

Join MASCC's buzzing online community
on FacebookTwitter & LinkedIn to hear the latest important news and converse with many colleagues who share your interests. 

MASCC-Designated Centers of Excellence in Supportive Care in Cancer - Learn more about MASCC Centers of Excellence and find applications at our website

Be a Voice for MASCC!
Say a few words about MASCC and our Annual Meeting at your next speaking engagement. See our Promotional Toolkit for some MASCC slides (Join MASCC and Save the Date) to add to your presentation. And join us in Seville for an exciting program featuring supportive care research advances and clinical applications.

Get Connected!

MASCC's Social Media Strategy Toolkit and Twitter Quick Guide were designed to help MASCC and its members establish a global social media presence. These guides will help you manage social media accounts and implement best practices for Twitter, Facebook, and LinkedIn in order to effectively disseminate MASCC's research and educational efforts, including new supportive care information and practice resources.

All MASCC Members, Study Groups, Staff, and Board Members are encouraged to use these tools and to engage regularly on social media platforms.

Future MASCC Meetings
Mark your calendar.


Supportive Care Positions

See the Supportive Care Positions page on the MASCC website for news about clinical and research positions in supportive cancer care. And let us know if you have a supportive cancer care position opening for a trainee, fellow, or senior scientist.

How to Access Our Journal, Supportive Care in Cancer

Your membership includes free access to the online version of our journal, Supportive Care in Cancer. Go to: and log in as a member. On the Member Landing Page, you will see a link to Proceed to the SCC Online Journal.

How to Access Annual Meeting Abstracts

Go to the online access of the journal (see above for access). Click on Browse Volumes & Issues. 

Then, click on June 2018, Issue 2 Supplement. There, you can read the issue or download a PDF of all the abstracts.


2019 Meeting Photo Gallery coming soon.  Stay tuned! 

This message has been sent to you because you are a MASCC member.
MASCC Privacy Notice  | Contact MASCC